tirzepatide injection area FDA ban on compounded tirzepatide: Switch to name brand medications What is the latest update

Eligible program participants, particularly those with insurance, and with an insurance prior authorization from their Sesame provider, may instead be prescribed name-brand GLP-1 medications depending upon the clinical judgment of their provider

Weight loss on these medications can include lean mass loss alongside fat loss

They live with ongoing conditions like type 2 diabetes or significant obesity

Headaches, fatigue, and dizziness occasionally accompany gastrointestinal symptoms, particularly during the dose titration phase when your medication strength increases every 4 weeks

Restaurant-quality food delivered to your doorperfect portions, perfect macros, zero stress